| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MRF binding | 1.32e-06 | 6 | 82 | 3 | GO:0043426 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOR2 PHC3 ARID1B KMT2A ANKRD17 NDN ASXL2 RERE TRIM24 PRDM15 CREBBP EP300 KDM1A PHF21A | 1.71e-06 | 739 | 82 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 1.57e-05 | 37 | 82 | 4 | GO:0043425 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.67e-05 | 2 | 82 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.67e-05 | 2 | 82 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.93e-05 | 15 | 82 | 3 | GO:1990247 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.98e-05 | 3 | 82 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | YTHDF1 NCOR2 ARID1B MRTFB RBM33 HIPK1 RETREG1 RERE WNK1 TRIM24 SPEN CREBBP EP300 YTHDF2 KDM1A | 6.69e-05 | 1160 | 82 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 8.42e-05 | 21 | 82 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOR2 ARID1B MRTFB HIPK1 RERE TRIM24 SPEN CREBBP EP300 KDM1A | 9.99e-05 | 562 | 82 | 10 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | YTHDF1 NCOR2 ARID1B MRTFB FNTA RBM33 HIPK1 RETREG1 RERE WNK1 TRIM24 SPEN CREBBP EP300 YTHDF2 KDM1A | 1.09e-04 | 1356 | 82 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.27e-04 | 24 | 82 | 3 | GO:0140517 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 2.48e-04 | 303 | 82 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.76e-04 | 31 | 82 | 3 | GO:0140033 | |
| GeneOntologyMolecularFunction | p53 binding | 2.85e-04 | 77 | 82 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.61e-04 | 229 | 82 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.79e-04 | 83 | 82 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 6.31e-04 | 582 | 82 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 7.31e-04 | 363 | 82 | 7 | GO:0106310 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 8.94e-04 | 11 | 82 | 2 | GO:0019870 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.01e-03 | 753 | 82 | 10 | GO:0008134 | |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.07e-03 | 12 | 82 | 2 | GO:0001851 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 1.47e-03 | 14 | 82 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.63e-03 | 417 | 82 | 7 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 1.69e-03 | 15 | 82 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.38e-03 | 446 | 82 | 7 | GO:0004674 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.54e-03 | 66 | 82 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.54e-03 | 66 | 82 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 3.02e-03 | 20 | 82 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | protein kinase activity | 3.21e-03 | 600 | 82 | 8 | GO:0004672 | |
| GeneOntologyMolecularFunction | RNA cap binding | 3.33e-03 | 21 | 82 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | opsonin binding | 4.70e-03 | 25 | 82 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | Notch binding | 5.47e-03 | 27 | 82 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 6.73e-03 | 30 | 82 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.38e-03 | 187 | 82 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | complement binding | 7.63e-03 | 32 | 82 | 2 | GO:0001848 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 8.10e-03 | 33 | 82 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 8.60e-03 | 709 | 82 | 8 | GO:0016773 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum organization | 4.30e-06 | 107 | 82 | 6 | GO:0007029 | |
| GeneOntologyBiologicalProcess | positive regulation of protein deacetylation | 7.12e-06 | 10 | 82 | 3 | GO:0090312 | |
| GeneOntologyBiologicalProcess | regulation of protein deacetylation | 9.83e-06 | 34 | 82 | 4 | GO:0090311 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | NCOR2 PHC3 MAGEL2 KLF5 HIPK1 PPHLN1 NDN ASXL2 RERE RREB1 TRIM24 SPEN CREBBP EP300 KDM1A PHF21A SCAF4 | 2.94e-05 | 1399 | 82 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | NCOR2 PHC3 MAGEL2 KLF5 HIPK1 PPHLN1 NDN ASXL2 RERE RREB1 TRIM24 SPEN CREBBP EP300 KDM1A PHF21A SCAF4 | 3.34e-05 | 1413 | 82 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | protein deacetylation | 3.63e-05 | 47 | 82 | 4 | GO:0006476 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | DHX15 YTHDF1 WBP11 PNN RBM33 SRRM4 LARP1 TAF4 TNRC6C KHDC4 RBM20 YTHDF2 SCAF4 | 6.31e-05 | 917 | 82 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | protein deacylation | 8.36e-05 | 58 | 82 | 4 | GO:0035601 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 9.32e-05 | 4 | 82 | 2 | GO:1904594 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 9.32e-05 | 4 | 82 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | regulation of heterochromatin formation | 1.15e-04 | 24 | 82 | 3 | GO:0031445 | |
| GeneOntologyBiologicalProcess | macromolecule deacylation | 1.16e-04 | 63 | 82 | 4 | GO:0098732 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 2.05e-04 | 29 | 82 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 2.32e-04 | 6 | 82 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | NCOR2 MAGEL2 KLF5 HIPK1 NDN ASXL2 RREB1 SPEN CREBBP EP300 KDM1A PHF21A SCAF4 | 2.50e-04 | 1053 | 82 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | VPS37C WASH6P SEC16B PLK2 SEC16A RETREG1 LARP1 EIF4G3 WNK1 EP300 | 2.50e-04 | 650 | 82 | 10 | GO:0061919 |
| GeneOntologyBiologicalProcess | autophagy | VPS37C WASH6P SEC16B PLK2 SEC16A RETREG1 LARP1 EIF4G3 WNK1 EP300 | 2.50e-04 | 650 | 82 | 10 | GO:0006914 |
| GeneOntologyBiologicalProcess | regulation of androgen receptor signaling pathway | 2.51e-04 | 31 | 82 | 3 | GO:0060765 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 2.76e-04 | 32 | 82 | 3 | GO:0035162 | |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 3.24e-04 | 7 | 82 | 2 | GO:1903288 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 3.41e-04 | 234 | 82 | 6 | GO:0006282 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.41e-04 | 151 | 82 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | HOXA4 MRTFB KLF5 ARID2 KMT2A NDN ASXL2 TAF4 RREB1 PRDM15 CREBBP EP300 ALX4 KDM1A NPAS2 | 3.42e-04 | 1390 | 82 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryonic organ development | 3.84e-04 | 561 | 82 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | stress granule assembly | 3.93e-04 | 36 | 82 | 3 | GO:0034063 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum exit site | 4.30e-04 | 8 | 82 | 2 | GO:0070973 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 cell lineage commitment | 4.30e-04 | 8 | 82 | 2 | GO:2000330 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 4.77e-04 | 91 | 82 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 5.21e-04 | 354 | 82 | 7 | GO:0071695 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 5.38e-04 | 40 | 82 | 3 | GO:1902275 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 5.52e-04 | 9 | 82 | 2 | GO:1903286 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ARID1B BICRA ARID2 KMT2A PPHLN1 NDN RERE TAF4 CREBBP EP300 KDM1A PHF21A | 5.64e-04 | 999 | 82 | 12 | GO:0071824 |
| GeneOntologyBiologicalProcess | rhythmic process | 5.76e-04 | 360 | 82 | 7 | GO:0048511 | |
| GeneOntologyBiologicalProcess | regulation of protein stability | 6.56e-04 | 368 | 82 | 7 | GO:0031647 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 6.98e-04 | 741 | 82 | 10 | GO:0006338 | |
| GeneOntologyBiologicalProcess | DNA methylation-dependent constitutive heterochromatin formation | 7.13e-04 | 44 | 82 | 3 | GO:0006346 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 7.61e-04 | 103 | 82 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | COPII-coated vesicle budding | 7.62e-04 | 45 | 82 | 3 | GO:0090114 | |
| GeneOntologyBiologicalProcess | chromatin organization | ARID1B BICRA ARID2 KMT2A PPHLN1 NDN RERE CREBBP EP300 KDM1A PHF21A | 8.17e-04 | 896 | 82 | 11 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of T-helper 17 cell lineage commitment | 8.39e-04 | 11 | 82 | 2 | GO:2000328 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 9.78e-04 | 49 | 82 | 3 | GO:0042771 | |
| GeneOntologyBiologicalProcess | signal transduction by p53 class mediator | 9.90e-04 | 191 | 82 | 5 | GO:0072331 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DHX15 NCOR2 PHC3 ARID1B PNN BICRA ARID2 CDK19 KMT2A POLR2M ASXL2 RERE TAF4 KHDC4 CREBBP PHF21A NPAS2 | 2.03e-05 | 1377 | 82 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.20e-05 | 42 | 82 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 9.03e-05 | 269 | 82 | 7 | GO:0036464 | |
| GeneOntologyCellularComponent | transcription regulator complex | 1.11e-04 | 596 | 82 | 10 | GO:0005667 | |
| GeneOntologyCellularComponent | ER to Golgi transport vesicle membrane | 1.17e-04 | 64 | 82 | 4 | GO:0012507 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.35e-04 | 287 | 82 | 7 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear body | DHX15 HOXA4 NCOR2 WBP11 PNN HIPK1 RETREG1 PTPN23 RERE RREB1 PRDM15 CREBBP | 2.01e-04 | 903 | 82 | 12 | GO:0016604 |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.19e-04 | 30 | 82 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 5.55e-04 | 96 | 82 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | chromatin | HOXA4 NCOR2 PLK2 ARID1B BICRA KLF5 ARID2 ANKRD17 TAF4 TRIM24 CREBBP EP300 ALX4 KDM1A NPAS2 | 5.76e-04 | 1480 | 82 | 15 | GO:0000785 |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 9.26e-04 | 110 | 82 | 4 | GO:0030134 | |
| HumanPheno | Autistic behavior | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 CAPN15 | 2.04e-08 | 678 | 33 | 18 | HP:0000729 |
| HumanPheno | Diagnostic behavioral phenotype | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 CAPN15 | 9.58e-08 | 747 | 33 | 18 | HP:0025783 |
| HumanPheno | Hypertrichosis | WBP11 ARID1B BICRA ARID2 KMT2A ASXL2 RERE TAF4 SPEN CREBBP EP300 KDM1A RAI1 CAPN15 | 1.20e-07 | 425 | 33 | 14 | HP:0000998 |
| HumanPheno | Restricted or repetitive behaviors or interests | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 | 1.80e-07 | 368 | 33 | 13 | HP:0031432 |
| HumanPheno | Perseverative thought | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 | 2.39e-07 | 377 | 33 | 13 | HP:0030223 |
| HumanPheno | Disordered formal thought process | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 | 3.15e-07 | 386 | 33 | 13 | HP:0025769 |
| HumanPheno | Abnormal nasal tip morphology | ARID1B BICRA ARID2 CDK19 KMT2A ASXL2 RERE RREB1 SPEN ALX4 KDM1A PHF21A SCAF4 | 3.15e-07 | 386 | 33 | 13 | HP:0000436 |
| HumanPheno | Simple ear | 3.24e-07 | 24 | 33 | 5 | HP:0020206 | |
| HumanPheno | Thick eyebrow | 3.46e-07 | 154 | 33 | 9 | HP:0000574 | |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN ASXL2 TAF4 SPEN CREBBP EP300 KDM1A RAI1 | 3.61e-07 | 464 | 33 | 14 | HP:0011339 |
| HumanPheno | Abnormal external nose morphology | ARID1B BICRA ARID2 CDK19 KMT2A ANKRD17 ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 SCAF4 CAPN15 | 3.74e-07 | 916 | 33 | 19 | HP:0010938 |
| HumanPheno | Facial hypertrichosis | 3.86e-07 | 206 | 33 | 10 | HP:0002219 | |
| HumanPheno | Autism | MAGEL2 CDK19 KMT2A NDN RERE TAF4 RREB1 SPEN CREBBP EP300 RAI1 | 4.12e-07 | 264 | 33 | 11 | HP:0000717 |
| HumanPheno | Congenital abnormal hair pattern | WBP11 ARID1B MAGEL2 BICRA ARID2 KMT2A ANKRD17 RERE SPEN CREBBP EP300 KDM1A | 4.17e-07 | 327 | 33 | 12 | HP:0011361 |
| HumanPheno | Upslanted palpebral fissure | ARID1B MAGEL2 BICRA ANKRD17 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 RAI1 | 5.09e-07 | 333 | 33 | 12 | HP:0000582 |
| HumanPheno | Abnormal thought pattern | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 | 5.36e-07 | 404 | 33 | 13 | HP:5200269 |
| HumanPheno | Thin upper lip vermilion | ARID1B MAGEL2 ARID2 KMT2A ANKRD17 NDN ASXL2 SPEN CREBBP EP300 KDM1A RAI1 | 6.17e-07 | 339 | 33 | 12 | HP:0000219 |
| HumanPheno | Thin lips | ARID1B MAGEL2 ARID2 KMT2A ANKRD17 NDN ASXL2 SPEN CREBBP EP300 KDM1A RAI1 | 6.17e-07 | 339 | 33 | 12 | HP:0000213 |
| HumanPheno | Feeding difficulties | ARID1B MAGEL2 BICRA ARID2 CDK19 RETREG1 KMT2A ANKRD17 PTPN23 NDN ASXL2 RERE TAF4 RREB1 WNK1 SPEN CREBBP EP300 KDM1A RAI1 SCAF4 | 6.22e-07 | 1168 | 33 | 21 | HP:0011968 |
| HumanPheno | Abnormally increased volition | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 KDM1A PHF21A RAI1 SCAF4 | 1.01e-06 | 869 | 33 | 18 | HP:5200263 |
| HumanPheno | Abnormal hair pattern | WBP11 ARID1B MAGEL2 BICRA ARID2 KMT2A ANKRD17 ASXL2 RERE TAF4 SPEN CREBBP EP300 KDM1A RAI1 CAPN15 | 1.01e-06 | 676 | 33 | 16 | HP:0010720 |
| HumanPheno | Abnormal upper lip morphology | ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 SCAF4 | 1.12e-06 | 980 | 33 | 19 | HP:0000177 |
| HumanPheno | Abnormality of the hairline | WBP11 ARID1B BICRA ARID2 KMT2A ANKRD17 RERE SPEN CREBBP EP300 KDM1A | 1.21e-06 | 294 | 33 | 11 | HP:0009553 |
| HumanPheno | Parietal foramina | 1.40e-06 | 14 | 33 | 4 | HP:0002697 | |
| HumanPheno | Disinhibition | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 2.00e-06 | 807 | 33 | 17 | HP:0000734 |
| HumanPheno | Inappropriate behavior | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 2.00e-06 | 807 | 33 | 17 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 2.00e-06 | 807 | 33 | 17 | HP:5200123 |
| HumanPheno | Social disinhibition | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 2.00e-06 | 807 | 33 | 17 | HP:5200029 |
| HumanPheno | Abnormal columella morphology | 2.08e-06 | 97 | 33 | 7 | HP:0009929 | |
| HumanPheno | Short philtrum | ARID1B ARID2 ANKRD17 TAF4 RREB1 SPEN CREBBP ALX4 PHF21A RAI1 | 2.57e-06 | 253 | 33 | 10 | HP:0000322 |
| HumanPheno | Slanting of the palpebral fissure | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A RAI1 | 3.41e-06 | 739 | 33 | 16 | HP:0200006 |
| HumanPheno | Hyperactivity | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 RERE RREB1 SPEN CREBBP EP300 PHF21A RAI1 | 3.45e-06 | 558 | 33 | 14 | HP:0000752 |
| HumanPheno | Abnormal stomach morphology | ARID1B MAGEL2 BICRA ARID2 CDK19 RETREG1 KMT2A NDN RERE RREB1 WNK1 SPEN CREBBP RNF43 EP300 RAI1 | 3.60e-06 | 742 | 33 | 16 | HP:0002577 |
| HumanPheno | Self-injurious behavior | 4.72e-06 | 210 | 33 | 9 | HP:0100716 | |
| HumanPheno | Abnormal hand morphology | ARID1B MAGEL2 BICRA ARID2 RETREG1 KMT2A RNF216 NDN ASXL2 RERE TAF4 RREB1 WNK1 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 5.38e-06 | 1082 | 33 | 19 | HP:0005922 |
| HumanPheno | Downslanted palpebral fissures | ARID1B BICRA ARID2 CDK19 KMT2A RERE TAF4 RREB1 SPEN CREBBP EP300 KDM1A RAI1 | 5.69e-06 | 497 | 33 | 13 | HP:0000494 |
| HumanPheno | Abnormality of the frontal hairline | 5.73e-06 | 215 | 33 | 9 | HP:0000599 | |
| HumanPheno | Abnormal eyebrow morphology | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ASXL2 RERE TAF4 SPEN CREBBP EP300 ALX4 KDM1A RAI1 | 5.90e-06 | 674 | 33 | 15 | HP:0000534 |
| HumanPheno | Hirsutism | 5.95e-06 | 216 | 33 | 9 | HP:0001007 | |
| HumanPheno | Motor stereotypy | 6.42e-06 | 280 | 33 | 10 | HP:0000733 | |
| HumanPheno | Abnormal nasal septum morphology | 6.54e-06 | 115 | 33 | 7 | HP:0000419 | |
| HumanPheno | Abnormality of the palpebral fissures | ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A RAI1 | 6.85e-06 | 880 | 33 | 17 | HP:0008050 |
| HumanPheno | Abnormal curvature of the vertebral column | ARID1B MAGEL2 BICRA ARID2 TMEM165 CDK19 RETREG1 KMT2A ANKRD17 NDN ASXL2 RERE TAF4 RREB1 WNK1 SPEN CREBBP EP300 RAI1 SCAF4 | 7.10e-06 | 1219 | 33 | 20 | HP:0010674 |
| HumanPheno | Feeding difficulties in infancy | ARID1B MAGEL2 RETREG1 PTPN23 NDN ASXL2 RERE TAF4 RREB1 WNK1 SPEN CREBBP EP300 RAI1 | 7.27e-06 | 594 | 33 | 14 | HP:0008872 |
| HumanPheno | Thin vermilion border | ARID1B MAGEL2 ARID2 KMT2A ANKRD17 NDN ASXL2 SPEN CREBBP EP300 KDM1A RAI1 | 8.30e-06 | 433 | 33 | 12 | HP:0000233 |
| HumanPheno | Aggressive behavior | ARID1B MAGEL2 ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 SCAF4 | 8.65e-06 | 516 | 33 | 13 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | ARID1B MAGEL2 ARID2 CDK19 KMT2A NDN RERE TAF4 SPEN CREBBP EP300 RAI1 SCAF4 | 8.65e-06 | 516 | 33 | 13 | HP:0006919 |
| HumanPheno | Gastroesophageal reflux | MAGEL2 BICRA ARID2 CDK19 RETREG1 KMT2A RERE RREB1 WNK1 SPEN CREBBP EP300 RAI1 | 8.84e-06 | 517 | 33 | 13 | HP:0002020 |
| HumanPheno | Short attention span | WBP11 MAGEL2 ARID2 CDK19 KMT2A ANKRD17 RERE RREB1 SPEN CREBBP EP300 PHF21A RAI1 | 8.84e-06 | 517 | 33 | 13 | HP:0000736 |
| HumanPheno | Abnormal social development | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 1.06e-05 | 908 | 33 | 17 | HP:0025732 |
| HumanPheno | Reduced attention regulation | WBP11 MAGEL2 ARID2 CDK19 KMT2A ANKRD17 RERE RREB1 SPEN CREBBP EP300 PHF21A RAI1 | 1.07e-05 | 526 | 33 | 13 | HP:5200044 |
| HumanPheno | Abnormal size of the palpebral fissures | 1.12e-05 | 298 | 33 | 10 | HP:0200007 | |
| HumanPheno | Abnormal calvaria morphology | WBP11 ARID1B MAGEL2 BICRA ARID2 CDK19 RETREG1 KMT2A ANKRD17 RNF216 RERE RREB1 WNK1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 | 1.13e-05 | 1254 | 33 | 20 | HP:0002683 |
| HumanPheno | Radial deviation of finger | ARID1B MAGEL2 KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 1.18e-05 | 448 | 33 | 12 | HP:0009466 |
| HumanPheno | Impairment in personality functioning | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 RNF216 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 KDM1A PHF21A RAI1 SCAF4 | 1.23e-05 | 1141 | 33 | 19 | HP:0031466 |
| HumanPheno | Abnormal scalp morphology | WBP11 ARID1B BICRA ARID2 KMT2A ANKRD17 RERE SPEN CREBBP EP300 ALX4 KDM1A | 1.24e-05 | 450 | 33 | 12 | HP:0001965 |
| HumanPheno | Abnormal eating behavior | 1.33e-05 | 128 | 33 | 7 | HP:0100738 | |
| HumanPheno | Long eyelashes | 1.40e-05 | 129 | 33 | 7 | HP:0000527 | |
| HumanPheno | Radial deviation of the hand or of fingers of the hand | ARID1B MAGEL2 KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 1.42e-05 | 456 | 33 | 12 | HP:0009485 |
| HumanPheno | Abnormality of the philtrum | ARID1B MAGEL2 ARID2 KMT2A ANKRD17 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 PHF21A RAI1 SCAF4 | 1.49e-05 | 726 | 33 | 15 | HP:0000288 |
| HumanPheno | Abnormal eyelid morphology | IL12RB1 ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 NDN ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 SCAF4 | 1.60e-05 | 1408 | 33 | 21 | HP:0000492 |
| HumanPheno | Abnormality of the thyroid gland | IL12RB1 ARID1B MAGEL2 BICRA ARID2 NDN RERE RREB1 SPEN CREBBP ALX4 PHF21A RAI1 | 1.68e-05 | 548 | 33 | 13 | HP:0000820 |
| HumanPheno | Abnormal morphology of the nasal alae | ARID1B BICRA ARID2 KMT2A ANKRD17 ASXL2 RERE TAF4 SPEN CREBBP ALX4 KDM1A PHF21A RAI1 | 1.72e-05 | 639 | 33 | 14 | HP:0000429 |
| HumanPheno | Joint hypermobility | ARID1B BICRA ARID2 TMEM165 KMT2A ANKRD17 TAF4 RREB1 CREBBP EP300 KDM1A RAI1 SCAF4 | 2.01e-05 | 557 | 33 | 13 | HP:0001382 |
| HumanPheno | Constipation | MAGEL2 BICRA ARID2 KMT2A RERE TAF4 RREB1 SPEN CREBBP EP300 KDM1A RAI1 | 2.02e-05 | 472 | 33 | 12 | HP:0002019 |
| HumanPheno | Anteverted nares | ARID1B BICRA ARID2 KMT2A ASXL2 RERE TAF4 SPEN CREBBP ALX4 KDM1A PHF21A RAI1 | 2.09e-05 | 559 | 33 | 13 | HP:0000463 |
| HumanPheno | Upturned nose | ARID1B BICRA ARID2 KMT2A ASXL2 RERE TAF4 SPEN CREBBP ALX4 KDM1A PHF21A RAI1 | 2.09e-05 | 559 | 33 | 13 | HP:0000427 |
| HumanPheno | Brachycephaly | 2.15e-05 | 253 | 33 | 9 | HP:0000248 | |
| HumanPheno | Tapered finger | 2.51e-05 | 141 | 33 | 7 | HP:0001182 | |
| HumanPheno | Low-set ears | WBP11 ARID1B MAGEL2 BICRA ARID2 TMEM165 KMT2A ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 | 2.67e-05 | 761 | 33 | 15 | HP:0000369 |
| HumanPheno | Clinodactyly | ARID1B MAGEL2 ARID2 KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 2.78e-05 | 574 | 33 | 13 | HP:0030084 |
| HumanPheno | Abnormal nostril morphology | ARID1B BICRA ARID2 KMT2A ASXL2 RERE TAF4 SPEN CREBBP ALX4 KDM1A PHF21A RAI1 | 2.83e-05 | 575 | 33 | 13 | HP:0005288 |
| HumanPheno | Premature adrenarche | 2.88e-05 | 10 | 33 | 3 | HP:0012412 | |
| HumanPheno | Increased body weight | CFH MAGEL2 NDN RERE RREB1 SPEN CREBBP EP300 KDM1A PHF21A RAI1 SCAF4 | 3.01e-05 | 491 | 33 | 12 | HP:0004324 |
| HumanPheno | Short columella | 3.09e-05 | 29 | 33 | 4 | HP:0002000 | |
| HumanPheno | Abnormal parietal bone morphology | 3.09e-05 | 29 | 33 | 4 | HP:0002696 | |
| HumanPheno | Broad eyebrow | 3.09e-05 | 29 | 33 | 4 | HP:0011229 | |
| HumanPheno | Highly arched eyebrow | 3.62e-05 | 206 | 33 | 8 | HP:0002553 | |
| HumanPheno | Clinodactyly of the 5th finger | ARID1B KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 3.83e-05 | 420 | 33 | 11 | HP:0004209 |
| HumanPheno | Clinodactyly of hands | ARID1B KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 3.92e-05 | 421 | 33 | 11 | HP:0001157 |
| HumanPheno | Deviation of the 5th finger | ARID1B KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 3.92e-05 | 421 | 33 | 11 | HP:0009179 |
| HumanPheno | Abnormal cardiac septum morphology | WBP11 ARID1B MAGEL2 BICRA ARID2 KMT2A ASXL2 RERE RREB1 SPEN CREBBP EP300 KDM1A RAI1 SCAF4 | 4.02e-05 | 787 | 33 | 15 | HP:0001671 |
| HumanPheno | Plantar crease between first and second toes | 4.07e-05 | 2 | 33 | 2 | HP:0008107 | |
| HumanPheno | Aortic isthmus hypoplasia | 4.07e-05 | 2 | 33 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 4.07e-05 | 2 | 33 | 2 | HP:0001042 | |
| HumanPheno | Self hugging | 4.07e-05 | 2 | 33 | 2 | HP:0032521 | |
| HumanPheno | Obesity | MAGEL2 NDN RERE RREB1 SPEN CREBBP EP300 KDM1A PHF21A RAI1 SCAF4 | 4.28e-05 | 425 | 33 | 11 | HP:0001513 |
| HumanPheno | Abnormal 5th finger morphology | ARID1B ARID2 KMT2A RNF216 RERE TAF4 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 4.33e-05 | 509 | 33 | 12 | HP:0004207 |
| HumanPheno | Localized skin lesion | IL12RB1 WBP11 ARID1B RETREG1 KMT2A ASXL2 RERE TAF4 RREB1 WNK1 SPEN CREBBP EP300 ALX4 KDM1A CAPN15 | 4.37e-05 | 897 | 33 | 16 | HP:0011355 |
| HumanPheno | Scoliosis | ARID1B MAGEL2 BICRA ARID2 TMEM165 CDK19 KMT2A ANKRD17 NDN ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 RAI1 SCAF4 | 4.43e-05 | 1122 | 33 | 18 | HP:0002650 |
| HumanPheno | Abnormal lip morphology | ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN ASXL2 RERE TAF4 RREB1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 SCAF4 | 4.84e-05 | 1249 | 33 | 19 | HP:0000159 |
| HumanPheno | Abnormality of the scalp hair | WBP11 ARID1B BICRA ARID2 KMT2A ANKRD17 RERE SPEN CREBBP EP300 KDM1A | 5.09e-05 | 433 | 33 | 11 | HP:0100037 |
| HumanPheno | Abnormality of calvarial morphology | WBP11 ARID1B MAGEL2 BICRA ARID2 CDK19 KMT2A ANKRD17 RNF216 RERE RREB1 SPEN CREBBP EP300 ALX4 KDM1A PHF21A RAI1 | 5.15e-05 | 1134 | 33 | 18 | HP:0002648 |
| HumanPheno | Syringomyelia | 5.23e-05 | 33 | 33 | 4 | HP:0003396 | |
| HumanPheno | Compulsive behaviors | 5.24e-05 | 158 | 33 | 7 | HP:0000722 | |
| HumanPheno | Abnormal eyelash morphology | 5.40e-05 | 284 | 33 | 9 | HP:0000499 | |
| HumanPheno | Epicanthus | ARID1B BICRA ARID2 KMT2A ASXL2 RERE RREB1 SPEN CREBBP EP300 ALX4 PHF21A SCAF4 | 5.73e-05 | 614 | 33 | 13 | HP:0000286 |
| HumanPheno | Abnormal aortic arch morphology | 5.79e-05 | 109 | 33 | 6 | HP:0012303 | |
| HumanPheno | Reduced impulse control | WBP11 ARID1B MAGEL2 ARID2 CDK19 KMT2A ANKRD17 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 PHF21A RAI1 SCAF4 | 6.12e-05 | 1032 | 33 | 17 | HP:5200045 |
| HumanPheno | Short stature | WBP11 ARID1B MAGEL2 BICRA ARID2 TMEM165 CDK19 KMT2A ANKRD17 RNF216 NDN RERE TAF4 RREB1 SPEN CREBBP EP300 KDM1A RAI1 CAPN15 | 7.02e-05 | 1407 | 33 | 20 | HP:0004322 |
| MousePheno | ventricular septal defect | 9.21e-06 | 261 | 74 | 9 | MP:0010402 | |
| MousePheno | abnormal heart ventricle morphology | NCOR2 MRTFB PNN BICRA ARID2 AAK1 ANKRD17 RERE RREB1 WNK1 PRDM15 CREBBP RBM20 EP300 KDM1A | 1.40e-05 | 793 | 74 | 15 | MP:0005294 |
| MousePheno | small heart | 4.73e-05 | 321 | 74 | 9 | MP:0002188 | |
| MousePheno | abnormal interventricular septum morphology | 7.70e-05 | 342 | 74 | 9 | MP:0000281 | |
| MousePheno | thin myocardium | 8.55e-05 | 85 | 74 | 5 | MP:0002652 | |
| MousePheno | small snout | 1.12e-04 | 144 | 74 | 6 | MP:0030190 | |
| MousePheno | perimembraneous ventricular septal defect | 1.25e-04 | 92 | 74 | 5 | MP:0010418 | |
| MousePheno | sternebra fusion | 1.30e-04 | 19 | 74 | 3 | MP:0010082 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 1.31e-04 | 93 | 74 | 5 | MP:0008823 | |
| MousePheno | abnormal heart septum morphology | 2.00e-04 | 388 | 74 | 9 | MP:0006113 | |
| MousePheno | abnormal embryo development | DHX15 WASH6P NCOR2 WBP11 PLK2 PNN BICRA KLF5 CLPTM1 LARP1 KMT2A ANKRD17 PTPN23 WNK1 PRDM15 CREBBP EP300 KDM1A | 2.18e-04 | 1370 | 74 | 18 | MP:0001672 |
| MousePheno | abnormal cardiac muscle tissue morphology | MRTFB ARID2 ANKRD17 POLR2M RREB1 WNK1 CREBBP RBM20 EP300 KDM1A | 2.41e-04 | 489 | 74 | 10 | MP:0010630 |
| MousePheno | abnormal cardiovascular development | NCOR2 ANGPTL6 MRTFB PNN KLF5 ARID2 ANKRD17 RERE WNK1 SPEN CREBBP EP300 KDM1A | 2.67e-04 | 802 | 74 | 13 | MP:0002925 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | PNN ARID2 KMT2A ANKRD17 PTPN23 POLR2M RERE TAF4 WNK1 CREBBP EP300 KDM1A | 2.85e-04 | 700 | 74 | 12 | MP:0011098 |
| MousePheno | abnormal heart size | ARID1B BICRA KLF5 SPRR3 CDK19 SIK2 LARP1 ANKRD17 POLR2M ASXL2 RREB1 WNK1 CREBBP RBM20 EP300 KDM1A | 3.71e-04 | 1180 | 74 | 16 | MP:0005406 |
| Domain | Nuc_rcpt_coact_CREBbp | 1.81e-05 | 2 | 80 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.81e-05 | 2 | 80 | 2 | PF08214 | |
| Domain | KIX | 1.81e-05 | 2 | 80 | 2 | PS50952 | |
| Domain | Sec16 | 1.81e-05 | 2 | 80 | 2 | IPR024880 | |
| Domain | Sec16 | 1.81e-05 | 2 | 80 | 2 | PF12932 | |
| Domain | ZnF_TAZ | 1.81e-05 | 2 | 80 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.81e-05 | 2 | 80 | 2 | IPR031162 | |
| Domain | DUF902 | 1.81e-05 | 2 | 80 | 2 | PF06001 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.81e-05 | 2 | 80 | 2 | IPR010303 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.81e-05 | 2 | 80 | 2 | PF09030 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.81e-05 | 2 | 80 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.81e-05 | 2 | 80 | 2 | PS50134 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.81e-05 | 2 | 80 | 2 | IPR013178 | |
| Domain | KAT11 | 1.81e-05 | 2 | 80 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.81e-05 | 2 | 80 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.81e-05 | 2 | 80 | 2 | IPR003101 | |
| Domain | KIX | 1.81e-05 | 2 | 80 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.81e-05 | 2 | 80 | 2 | PS51727 | |
| Domain | Sec16_CCD | 1.81e-05 | 2 | 80 | 2 | IPR024340 | |
| Domain | BROMODOMAIN_2 | 2.80e-05 | 41 | 80 | 4 | PS50014 | |
| Domain | BROMO | 3.09e-05 | 42 | 80 | 4 | SM00297 | |
| Domain | Bromodomain | 3.09e-05 | 42 | 80 | 4 | IPR001487 | |
| Domain | - | 3.09e-05 | 42 | 80 | 4 | 1.20.920.10 | |
| Domain | Sec16_C | 5.42e-05 | 3 | 80 | 2 | PF12931 | |
| Domain | ACE1_Sec16_Sec31 | 5.42e-05 | 3 | 80 | 2 | IPR024298 | |
| Domain | ZF_PHD_2 | 5.45e-05 | 95 | 80 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 5.73e-05 | 96 | 80 | 5 | PS01359 | |
| Domain | SUZ | 1.08e-04 | 4 | 80 | 2 | IPR024771 | |
| Domain | SUZ | 1.08e-04 | 4 | 80 | 2 | PS51673 | |
| Domain | YTH_domain | 1.80e-04 | 5 | 80 | 2 | IPR007275 | |
| Domain | YTH | 1.80e-04 | 5 | 80 | 2 | PS50882 | |
| Domain | YTH | 1.80e-04 | 5 | 80 | 2 | PF04146 | |
| Domain | Bromodomain_CS | 1.83e-04 | 26 | 80 | 3 | IPR018359 | |
| Domain | Kinase_OSR1/WNK_CCT | 2.69e-04 | 6 | 80 | 2 | IPR024678 | |
| Domain | Nuc_rcpt_coact | 2.69e-04 | 6 | 80 | 2 | IPR009110 | |
| Domain | OSR1_C | 2.69e-04 | 6 | 80 | 2 | PF12202 | |
| Domain | BROMODOMAIN_1 | 5.29e-04 | 37 | 80 | 3 | PS00633 | |
| Domain | Bromodomain | 5.73e-04 | 38 | 80 | 3 | PF00439 | |
| Domain | PHD | 5.78e-04 | 89 | 80 | 4 | SM00249 | |
| Domain | Znf_PHD | 6.29e-04 | 91 | 80 | 4 | IPR001965 | |
| Domain | R3H | 6.40e-04 | 9 | 80 | 2 | SM00393 | |
| Domain | Ser/Thr_kinase_AS | 8.44e-04 | 357 | 80 | 7 | IPR008271 | |
| Domain | S_TKc | 8.72e-04 | 359 | 80 | 7 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 9.16e-04 | 362 | 80 | 7 | PS00108 | |
| Domain | R3H | 9.72e-04 | 11 | 80 | 2 | PS51061 | |
| Domain | R3H | 9.72e-04 | 11 | 80 | 2 | PF01424 | |
| Domain | - | 9.72e-04 | 11 | 80 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 9.72e-04 | 11 | 80 | 2 | IPR001374 | |
| Domain | Pkinase | 1.23e-03 | 381 | 80 | 7 | PF00069 | |
| Domain | - | 1.83e-03 | 15 | 80 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.83e-03 | 15 | 80 | 2 | SM00501 | |
| Domain | ARID_dom | 1.83e-03 | 15 | 80 | 2 | IPR001606 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PS51011 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PF01388 | |
| Domain | AT_hook | 2.09e-03 | 16 | 80 | 2 | PF02178 | |
| Domain | RRM | 2.40e-03 | 217 | 80 | 5 | SM00360 | |
| Domain | ZZ | 2.65e-03 | 18 | 80 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.65e-03 | 18 | 80 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.65e-03 | 18 | 80 | 2 | PS01357 | |
| Domain | RRM_dom | 2.91e-03 | 227 | 80 | 5 | IPR000504 | |
| Domain | Znf_ZZ | 2.96e-03 | 19 | 80 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.96e-03 | 19 | 80 | 2 | SM00291 | |
| Domain | RRM | 3.08e-03 | 230 | 80 | 5 | PS50102 | |
| Domain | PROTEIN_KINASE_ATP | 3.51e-03 | 459 | 80 | 7 | PS00107 | |
| Domain | EPHD | 3.96e-03 | 22 | 80 | 2 | PS51805 | |
| Domain | - | 3.96e-03 | 244 | 80 | 5 | 3.30.70.330 | |
| Domain | PHD | 4.09e-03 | 75 | 80 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 4.74e-03 | 79 | 80 | 3 | IPR019787 | |
| Domain | Prot_kinase_dom | 4.95e-03 | 489 | 80 | 7 | IPR000719 | |
| Domain | Nucleotide-bd_a/b_plait | 5.01e-03 | 258 | 80 | 5 | IPR012677 | |
| Domain | PROTEIN_KINASE_DOM | 5.17e-03 | 493 | 80 | 7 | PS50011 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.24e-06 | 48 | 56 | 5 | M288 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 3.13e-06 | 26 | 56 | 4 | M2499 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.10e-05 | 272 | 56 | 8 | M29619 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.34e-05 | 37 | 56 | 4 | M27797 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.34e-05 | 37 | 56 | 4 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.00e-05 | 84 | 56 | 5 | M1008 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 2.69e-05 | 44 | 56 | 4 | M27295 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.51e-05 | 47 | 56 | 4 | M29777 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 4.00e-05 | 237 | 56 | 7 | M27786 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.14e-05 | 49 | 56 | 4 | M41832 | |
| Pathway | REACTOME_ADIPOGENESIS | 7.35e-05 | 110 | 56 | 5 | M48259 | |
| Pathway | PID_NOTCH_PATHWAY | 8.64e-05 | 59 | 56 | 4 | M17 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.03e-04 | 118 | 56 | 5 | M27316 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.54e-04 | 5 | 56 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.54e-04 | 5 | 56 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.54e-04 | 5 | 56 | 2 | M48023 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 1.59e-04 | 69 | 56 | 4 | M27113 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.69e-04 | 70 | 56 | 4 | M938 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 2.23e-04 | 30 | 56 | 3 | M207 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.30e-04 | 6 | 56 | 2 | M22062 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 2.30e-04 | 6 | 56 | 2 | M47880 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.21e-04 | 7 | 56 | 2 | MM1573 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 3.25e-04 | 83 | 56 | 4 | MM14819 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 3.26e-04 | 34 | 56 | 3 | M46422 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 4.27e-04 | 8 | 56 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.27e-04 | 8 | 56 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 4.27e-04 | 8 | 56 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.27e-04 | 8 | 56 | 2 | M46443 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 4.62e-04 | 91 | 56 | 4 | M39700 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M47451 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 6.83e-04 | 10 | 56 | 2 | M27945 | |
| Pathway | PID_HNF3A_PATHWAY | 7.01e-04 | 44 | 56 | 3 | M285 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.33e-04 | 11 | 56 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 8.33e-04 | 11 | 56 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.33e-04 | 11 | 56 | 2 | M26924 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 8.51e-04 | 47 | 56 | 3 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.05e-04 | 48 | 56 | 3 | M611 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 9.97e-04 | 12 | 56 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 9.97e-04 | 12 | 56 | 2 | M27765 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.14e-03 | 52 | 56 | 3 | M2404 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.18e-03 | 13 | 56 | 2 | MM15622 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.19e-03 | 201 | 56 | 5 | M39605 | |
| Pathway | PID_AR_TF_PATHWAY | 1.21e-03 | 53 | 56 | 3 | M151 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 1.35e-03 | 55 | 56 | 3 | MM14932 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.37e-03 | 14 | 56 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.57e-03 | 58 | 56 | 3 | M29616 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.57e-03 | 15 | 56 | 2 | MM1439 | |
| Pathway | WP_RUBINSTEINTAYBI_SYNDROME_1 | 1.57e-03 | 15 | 56 | 2 | M48323 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 1.57e-03 | 15 | 56 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.79e-03 | 16 | 56 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.79e-03 | 16 | 56 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.79e-03 | 16 | 56 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.79e-03 | 16 | 56 | 2 | M27940 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.82e-03 | 61 | 56 | 3 | M39540 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.03e-03 | 17 | 56 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 2.03e-03 | 17 | 56 | 2 | M48025 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 2.08e-03 | 64 | 56 | 3 | M200 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 2.28e-03 | 66 | 56 | 3 | M101 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.28e-03 | 18 | 56 | 2 | M26942 | |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | VPS37C NCOR2 FNTA CDK19 LARP1 TAF4 CREBBP EP300 KDM1A PHF21A | 2.36e-03 | 888 | 56 | 10 | M48034 |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.54e-03 | 19 | 56 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 2.54e-03 | 19 | 56 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.81e-03 | 20 | 56 | 2 | M27881 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.87e-03 | 149 | 56 | 4 | M27888 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.95e-03 | 360 | 56 | 6 | M27267 | |
| Pathway | REACTOME_INFECTIOUS_DISEASE | VPS37C NCOR2 PLK2 FNTA CDK19 LARP1 TAF4 CREBBP EP300 KDM1A PHF21A | 3.10e-03 | 1081 | 56 | 11 | M27548 |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 3.10e-03 | 21 | 56 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 3.10e-03 | 21 | 56 | 2 | M27485 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 3.15e-03 | 74 | 56 | 3 | M616 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 3.39e-03 | 156 | 56 | 4 | M27097 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.40e-03 | 22 | 56 | 2 | MM1443 | |
| Pathway | REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES | 3.40e-03 | 22 | 56 | 2 | M46437 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.40e-03 | 22 | 56 | 2 | MM1370 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 3.72e-03 | 23 | 56 | 2 | M2821 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.04e-03 | 24 | 56 | 2 | M13404 | |
| Pathway | REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA | 4.21e-03 | 82 | 56 | 3 | M1002 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 4.21e-03 | 82 | 56 | 3 | MM15922 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.39e-03 | 25 | 56 | 2 | M27880 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 4.42e-03 | 168 | 56 | 4 | MM14785 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 4.74e-03 | 26 | 56 | 2 | M32 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 4.74e-03 | 26 | 56 | 2 | M47923 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.10e-03 | 175 | 56 | 4 | MM14941 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 5.10e-03 | 27 | 56 | 2 | M26943 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | 5.30e-03 | 89 | 56 | 3 | M27943 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 5.48e-03 | 28 | 56 | 2 | M48253 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 5.48e-03 | 28 | 56 | 2 | M27254 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.48e-03 | 28 | 56 | 2 | M6177 | |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 6.17e-03 | 94 | 56 | 3 | M27230 | |
| Pathway | WP_FAMILIAL_PARTIAL_LIPODYSTROPHY | 6.28e-03 | 30 | 56 | 2 | M42537 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 6.28e-03 | 30 | 56 | 2 | M936 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 6.29e-03 | 296 | 56 | 5 | M27869 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 6.44e-03 | 187 | 56 | 4 | M961 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 6.54e-03 | 96 | 56 | 3 | M27792 | |
| Pathway | REACTOME_SUMOYLATION | 6.68e-03 | 189 | 56 | 4 | M27214 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 6.74e-03 | 301 | 56 | 5 | MM15983 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 6.92e-03 | 98 | 56 | 3 | M48247 | |
| Pubmed | YTHDF1 NCOR2 PHC3 ANGPTL6 WBP11 ARID1B PNN RBM33 BICRA PRRC2C KLF5 ARID2 SEC16A LARP1 KMT2A ANKRD17 HELZ R3HDM2 ASXL2 RERE TAF4 TNRC6C RREB1 TRIM24 SPEN CREBBP RBM20 EP300 YTHDF2 KDM1A PHF21A SCAF4 | 2.53e-23 | 1429 | 82 | 32 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOR2 ARID1B BICRA ARID2 SEC16A KMT2A ASXL2 RERE TAF4 RREB1 TRIM24 SPEN CREBBP EP300 KDM1A PHF21A RAI1 | 7.09e-18 | 351 | 82 | 17 | 38297188 |
| Pubmed | DHX15 NCOR2 WBP11 ARID1B RBM33 BICRA PRRC2C KLF5 ARID2 LARP1 KMT2A ASXL2 TAF4 RREB1 TRIM24 SPEN KHDC4 CREBBP ZYX EP300 KDM1A PHF21A RAI1 SCAF4 | 4.74e-17 | 1103 | 82 | 24 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DHX15 YTHDF1 NCOR2 PHC3 WBP11 ARID1B PNN RBM33 BICRA PRRC2C ARID2 SEC16A LARP1 KMT2A PPHLN1 TAF4 RREB1 TRIM24 SPEN YTHDF2 RAI1 SCAF4 | 3.69e-16 | 954 | 82 | 22 | 36373674 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | YTHDF1 NCOR2 ARID1B RBM33 PRRC2C SEC23IP SEC16A ANKRD17 HELZ TRIM24 KHDC4 CREBBP RBM20 EP300 YTHDF2 RAI1 | 1.15e-14 | 457 | 82 | 16 | 32344865 |
| Pubmed | ARID1B MRTFB PNN PRRC2C ARID2 SEC23IP SEC16A LARP1 KMT2A PTPN23 TAF4 SPEN CREBBP ZYX EP300 KDM1A SCAF4 | 1.15e-14 | 549 | 82 | 17 | 38280479 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PHC3 MRTFB PNN PRRC2C ARID2 SEC23IP SEC16A AAK1 LARP1 KMT2A ANKRD17 PTPN23 HELZ EIF4G3 WNK1 ZYX YTHDF2 PHF21A SCAF4 | 4.75e-13 | 934 | 82 | 19 | 33916271 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOR2 PHC3 ARID1B BICRA ARID2 SEC16A LARP1 RREB1 TRIM24 CREBBP RBM20 EP300 PHF21A | 1.04e-11 | 398 | 82 | 13 | 35016035 |
| Pubmed | ARID1B PNN RBM33 KLF5 KMT2A RERE TRIM24 CREBBP KDM1A PHF21A RAI1 | 4.00e-11 | 268 | 82 | 11 | 33640491 | |
| Pubmed | NCOR2 ARID1B BICRA ARID2 TMEM165 SEC16A ANKRD17 HELZ RERE TAF4 RREB1 TRIM24 CREBBP RNF43 EP300 KDM1A PHF21A RAI1 | 9.57e-11 | 1116 | 82 | 18 | 31753913 | |
| Pubmed | 1.02e-10 | 152 | 82 | 9 | 38360978 | ||
| Pubmed | NCOR2 PHC3 MRTFB SEC23IP SEC16A ANKRD17 RERE RREB1 TRIM24 RBM20 KDM1A PHF21A | 3.01e-10 | 418 | 82 | 12 | 34709266 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SEC16B NCOR2 PHC3 PNN SEC16A AAK1 LARP1 KMT2A ANKRD17 HELZ RERE RREB1 SPEN ZYX SCAF4 | 3.56e-10 | 774 | 82 | 15 | 15302935 |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 5.13e-10 | 40 | 82 | 6 | 34585037 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | DHX15 NCOR2 WBP11 SEC16A AAK1 LARP1 TAF4 TRIM24 CREBBP ZYX YTHDF2 PHF21A | 5.98e-10 | 444 | 82 | 12 | 34795231 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | NCOR2 MRTFB RBM33 PRRC2C HIPK1 ARID2 SEC16A HELZ WNK1 SPEN CREBBP RBM20 KDM1A | 1.24e-09 | 588 | 82 | 13 | 38580884 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOR2 MRTFB BICRA CDK19 AAK1 LARP1 ANKRD17 PPHLN1 RERE TAF4 TNRC6C EIF4G3 PRDM15 CREBBP EP300 ALX4 WNK2 RAI1 NPAS2 | 1.34e-09 | 1489 | 82 | 19 | 28611215 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DHX15 YTHDF1 SPATS2L LPCAT2 RBM33 PRRC2C AAK1 LARP1 ANKRD17 HELZ EIF4G3 SPEN ZYX YTHDF2 | 1.51e-09 | 724 | 82 | 14 | 36232890 |
| Pubmed | RBM33 BICRA HIPK1 ARID2 ANKRD17 PTPN23 HELZ WNK1 CREBBP ZYX EP300 WNK2 | 1.66e-09 | 486 | 82 | 12 | 20936779 | |
| Pubmed | NCOR2 WBP11 PNN RBM33 BICRA PRRC2C SEC16A LARP1 WNK1 ZYX YTHDF2 | 2.67e-09 | 399 | 82 | 11 | 35987950 | |
| Pubmed | DHX15 NCOR2 PNN PRRC2C SEC16A LARP1 ANKRD17 HELZ RERE TAF4 ZYX YTHDF2 KDM1A | 4.52e-09 | 655 | 82 | 13 | 35819319 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOR2 PHC3 MAGEL2 MRTFB BICRA KLF5 ARID2 EIF4G3 WNK1 SPEN WNK2 | 5.79e-09 | 430 | 82 | 11 | 35044719 |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 5.96e-09 | 10 | 82 | 4 | 30595551 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DHX15 YTHDF1 WBP11 SPATS2L PNN RBM33 PRRC2C LARP1 HELZ PPHLN1 EIF4G3 SPEN YTHDF2 SCAF4 | 6.00e-09 | 807 | 82 | 14 | 22681889 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCOR2 PRRC2C HIPK1 LARP1 ANKRD17 ASXL2 TRIM24 SPEN PRDM15 CREBBP EP300 ALX4 KDM1A PHF21A | 1.28e-08 | 857 | 82 | 14 | 25609649 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCDC88C PLK2 PRRC2C SEC16A AAK1 SIK2 LARP1 KMT2A ANKRD17 HELZ EIF4G3 WNK1 ZYX YTHDF2 | 1.35e-08 | 861 | 82 | 14 | 36931259 |
| Pubmed | YTHDF1 WBP11 ARID1B RBM33 CLPTM1 SEC23IP SEC16A LARP1 HELZ PPHLN1 RREB1 WNK1 YTHDF2 | 1.71e-08 | 733 | 82 | 13 | 34672954 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | YTHDF1 PLK2 MRTFB RBM33 KLF5 SEC23IP SEC16A AAK1 SIK2 RNF216 POLR2M TNRC6C WNK1 ZYX YTHDF2 | 1.85e-08 | 1038 | 82 | 15 | 26673895 |
| Pubmed | 3.20e-08 | 78 | 82 | 6 | 28611094 | ||
| Pubmed | NCOR2 ARID1B ARID2 TMEM165 SEC23IP ANKRD17 SEC31B TRIM24 SPEN CREBBP EP300 RAI1 | 3.37e-08 | 638 | 82 | 12 | 31182584 | |
| Pubmed | DHX15 PNN PRRC2C SEC16A LARP1 KMT2A ANKRD17 HELZ EIF4G3 SPEN KDM1A RAI1 | 4.34e-08 | 653 | 82 | 12 | 22586326 | |
| Pubmed | 4.66e-08 | 83 | 82 | 6 | 28794006 | ||
| Pubmed | Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. | 5.04e-08 | 4 | 82 | 3 | 17707401 | |
| Pubmed | Direct association between the CREB-binding protein (CBP) and nuclear receptor corepressor (N-CoR). | 5.04e-08 | 4 | 82 | 3 | 17073437 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DHX15 NCOR2 PHC3 PNN KLF5 KMT2A PPHLN1 ASXL2 TAF4 RREB1 SPEN EP300 KDM1A PHF21A RAI1 SCAF4 | 5.08e-08 | 1294 | 82 | 16 | 30804502 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.38e-08 | 220 | 82 | 8 | 35785414 | |
| Pubmed | Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. | 1.26e-07 | 5 | 82 | 3 | 11931765 | |
| Pubmed | 1.35e-07 | 20 | 82 | 4 | 11877444 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | YTHDF1 PRRC2C LARP1 ANKRD17 HELZ EIF4G3 WNK1 YTHDF2 WNK2 KDM1A | 1.42e-07 | 462 | 82 | 10 | 31138677 |
| Pubmed | 2.16e-07 | 177 | 82 | 7 | 26206133 | ||
| Pubmed | Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. | 2.95e-07 | 113 | 82 | 6 | 23403292 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DHX15 YTHDF1 NCOR2 PRRC2C SEC16A LARP1 KMT2A ANKRD17 PTPN23 HELZ EP300 | 3.18e-07 | 639 | 82 | 11 | 23443559 |
| Pubmed | WASH6P WBP11 PRRC2C SIK2 LARP1 KMT2A ANKRD17 HELZ RNF216 RBM20 YTHDF2 | 3.76e-07 | 650 | 82 | 11 | 38777146 | |
| Pubmed | 4.39e-07 | 7 | 82 | 3 | 18500350 | ||
| Pubmed | BICRA ARID2 TMEM165 SEC16A KMT2A ANKRD17 HELZ PPHLN1 RERE TAF4 WNK1 KHDC4 EP300 YTHDF2 CAPN15 | 4.42e-07 | 1327 | 82 | 15 | 32694731 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.86e-07 | 123 | 82 | 6 | 26912792 | |
| Pubmed | 5.14e-07 | 66 | 82 | 5 | 23275444 | ||
| Pubmed | 5.20e-07 | 407 | 82 | 9 | 12693553 | ||
| Pubmed | 5.44e-07 | 298 | 82 | 8 | 30737378 | ||
| Pubmed | DHX15 YTHDF1 SEC16B PHC3 WBP11 SPATS2L PRRC2C SEC16A AAK1 LARP1 KMT2A ANKRD17 PPHLN1 YTHDF2 SCAF4 | 6.66e-07 | 1371 | 82 | 15 | 36244648 | |
| Pubmed | 7.01e-07 | 8 | 82 | 3 | 20935208 | ||
| Pubmed | 7.01e-07 | 8 | 82 | 3 | 17475621 | ||
| Pubmed | DHX15 CCDC88C PNN PRRC2C SEC16A LARP1 PPHLN1 TAF4 ZYX YTHDF2 | 7.07e-07 | 551 | 82 | 10 | 34728620 | |
| Pubmed | 8.28e-07 | 216 | 82 | 7 | 31519766 | ||
| Pubmed | DHX15 PRRC2C TMEM165 SEC23IP SEC16A AAK1 LARP1 ANKRD17 PTPN23 EIF4G3 YTHDF2 | 8.69e-07 | 708 | 82 | 11 | 39231216 | |
| Pubmed | 9.76e-07 | 75 | 82 | 5 | 25593309 | ||
| Pubmed | 1.09e-06 | 225 | 82 | 7 | 12168954 | ||
| Pubmed | 1.17e-06 | 449 | 82 | 9 | 31732153 | ||
| Pubmed | 1.35e-06 | 80 | 82 | 5 | 35803934 | ||
| Pubmed | 1.43e-06 | 339 | 82 | 8 | 30415952 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.71e-06 | 608 | 82 | 10 | 36089195 | |
| Pubmed | PHC3 MRTFB SPATS2L RBM33 ARID2 AAK1 KMT2A ANKRD17 HELZ PPHLN1 TAF4 EIF4G3 SPEN KDM1A SCAF4 | 1.98e-06 | 1497 | 82 | 15 | 31527615 | |
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.06e-06 | 11 | 82 | 3 | 15681609 | |
| Pubmed | CCDC88C NCOR2 WBP11 PRRC2C SEC23IP SEC16A AAK1 ANKRD17 TAF4 WNK2 KDM1A RAI1 | 2.65e-06 | 963 | 82 | 12 | 28671696 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.70e-06 | 258 | 82 | 7 | 37794589 | |
| Pubmed | Regulation of LSD1 histone demethylase activity by its associated factors. | 2.74e-06 | 12 | 82 | 3 | 16140033 | |
| Pubmed | Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. | 2.74e-06 | 12 | 82 | 3 | 14645221 | |
| Pubmed | 2.89e-06 | 645 | 82 | 10 | 25281560 | ||
| Pubmed | 2.97e-06 | 503 | 82 | 9 | 16964243 | ||
| Pubmed | Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. | 3.97e-06 | 45 | 82 | 4 | 21258344 | |
| Pubmed | 4.34e-06 | 46 | 82 | 4 | 34265304 | ||
| Pubmed | 4.46e-06 | 529 | 82 | 9 | 14621295 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | DHX15 YTHDF1 WBP11 SPATS2L PRRC2C SEC16A LARP1 ANKRD17 HELZ YTHDF2 | 4.49e-06 | 678 | 82 | 10 | 30209976 |
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 11331592 | ||
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 4.51e-06 | 14 | 82 | 3 | 15333839 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 27881875 | ||
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 5.49e-06 | 2 | 82 | 2 | 34845315 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19729597 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15860545 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29460469 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 5.49e-06 | 2 | 82 | 2 | 24551300 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 16299065 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 33911074 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9018065 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24648406 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 30135524 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 39287984 | ||
| Pubmed | Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. | 5.49e-06 | 2 | 82 | 2 | 26970896 | |
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 5.49e-06 | 2 | 82 | 2 | 16596650 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 34408926 | ||
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 5.49e-06 | 2 | 82 | 2 | 29217654 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 12205094 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20717166 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 10049825 | ||
| Pubmed | N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency. | 5.49e-06 | 2 | 82 | 2 | 26046440 | |
| Pubmed | The mechanism underlying redundant functions of the YTHDF proteins. | 5.49e-06 | 2 | 82 | 2 | 36694229 | |
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 5.49e-06 | 2 | 82 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 5.49e-06 | 2 | 82 | 2 | 29170789 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25893291 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 11559821 | ||
| Interaction | TLE3 interactions | NCOR2 PHC3 ARID1B KLF5 ARID2 KMT2A HELZ RNF216 ASXL2 RERE TAF4 SPEN KHDC4 CREBBP RBM20 EP300 KDM1A SCAF4 | 9.87e-15 | 376 | 82 | 18 | int:TLE3 |
| Interaction | ALG13 interactions | YTHDF1 NCOR2 ARID1B RBM33 PRRC2C SEC16A HELZ R3HDM2 RERE RNF43 ZYX RBM20 EP300 YTHDF2 | 2.01e-14 | 183 | 82 | 14 | int:ALG13 |
| Interaction | SMG7 interactions | YTHDF1 NCOR2 ARID1B RBM33 SEC16A ANKRD17 HELZ R3HDM2 TNRC6C TRIM24 CREBBP RNF43 ZYX RBM20 YTHDF2 KDM1A | 1.74e-13 | 319 | 82 | 16 | int:SMG7 |
| Interaction | FEV interactions | NCOR2 PHC3 ARID1B BICRA ARID2 KMT2A ASXL2 TAF4 RREB1 TRIM24 CREBBP EP300 PHF21A | 1.81e-12 | 203 | 82 | 13 | int:FEV |
| Interaction | CRX interactions | VPS37C NCOR2 ARID1B BICRA ARID2 ASXL2 RERE RREB1 TRIM24 SPEN CREBBP EP300 RAI1 NPAS2 | 1.83e-12 | 254 | 82 | 14 | int:CRX |
| Interaction | EGR2 interactions | NCOR2 ARID1B BICRA ARID2 SEC16A KMT2A RERE RREB1 TRIM24 CREBBP EP300 PHF21A | 4.67e-12 | 171 | 82 | 12 | int:EGR2 |
| Interaction | CEBPA interactions | DHX15 NCOR2 WBP11 ARID1B PNN RBM33 BICRA PRRC2C KLF5 ARID2 LARP1 KMT2A ASXL2 TAF4 RREB1 TRIM24 SPEN KHDC4 CREBBP ZYX EP300 KDM1A PHF21A RAI1 SCAF4 | 1.16e-11 | 1245 | 82 | 25 | int:CEBPA |
| Interaction | NUP35 interactions | YTHDF1 NCOR2 ARID1B RBM33 PRRC2C SEC23IP SEC16A ANKRD17 HELZ TRIM24 KHDC4 CREBBP RBM20 EP300 YTHDF2 RAI1 | 1.31e-11 | 424 | 82 | 16 | int:NUP35 |
| Interaction | SP7 interactions | NCOR2 WBP11 ARID1B PNN RBM33 BICRA ARID2 RERE TRIM24 CREBBP RBM20 EP300 KDM1A SCAF4 | 2.05e-11 | 304 | 82 | 14 | int:SP7 |
| Interaction | HELZ interactions | YTHDF1 NCOR2 PRRC2C SEC16A ANKRD17 HELZ R3HDM2 TNRC6C TRIM24 CREBBP RNF43 ZYX YTHDF2 | 3.56e-11 | 257 | 82 | 13 | int:HELZ |
| Interaction | SOX7 interactions | 4.48e-11 | 82 | 82 | 9 | int:SOX7 | |
| Interaction | SMC5 interactions | DHX15 YTHDF1 NCOR2 PHC3 WBP11 ARID1B PNN RBM33 BICRA PRRC2C ARID2 SEC16A LARP1 KMT2A PPHLN1 TAF4 RREB1 TRIM24 SPEN YTHDF2 RAI1 SCAF4 | 4.75e-11 | 1000 | 82 | 22 | int:SMC5 |
| Interaction | FHL2 interactions | NCOR2 PHC3 MAGEL2 MRTFB PRRC2C HIPK1 ANKRD17 ASXL2 WNK1 SPEN CREBBP EP300 ALX4 PHF21A NPAS2 | 5.81e-11 | 396 | 82 | 15 | int:FHL2 |
| Interaction | KLF8 interactions | NCOR2 BICRA PRRC2C ARID2 SEC16A LARP1 TAF4 RREB1 TRIM24 SPEN CREBBP EP300 YTHDF2 PHF21A | 5.87e-11 | 329 | 82 | 14 | int:KLF8 |
| Interaction | TNRC6A interactions | YTHDF1 SEC16A ANKRD17 HELZ R3HDM2 TNRC6C WNK1 TRIM24 RNF43 ZYX YTHDF2 KDM1A PHF21A | 1.03e-10 | 280 | 82 | 13 | int:TNRC6A |
| Interaction | TNRC6B interactions | YTHDF1 SEC16A ANKRD17 PTPN23 HELZ R3HDM2 TNRC6C TRIM24 RNF43 ZYX YTHDF2 KDM1A PHF21A | 1.13e-10 | 282 | 82 | 13 | int:TNRC6B |
| Interaction | CNOT2 interactions | YTHDF1 NCOR2 PRRC2C TMEM165 SEC16A LARP1 ANKRD17 HELZ R3HDM2 TNRC6C YTHDF2 | 1.52e-10 | 178 | 82 | 11 | int:CNOT2 |
| Interaction | FUBP3 interactions | YTHDF1 RBM33 PRRC2C KLF5 SEC16A ANKRD17 HELZ R3HDM2 TNRC6C RNF43 RBM20 EP300 YTHDF2 | 2.14e-10 | 297 | 82 | 13 | int:FUBP3 |
| Interaction | EIF4ENIF1 interactions | YTHDF1 PRRC2C SEC16A ANKRD17 HELZ R3HDM2 EIF4G3 TRIM24 CREBBP RNF43 YTHDF2 KDM1A PHF21A | 2.42e-10 | 300 | 82 | 13 | int:EIF4ENIF1 |
| Interaction | YTHDF2 interactions | YTHDF1 MAGEL2 PRRC2C ANKRD17 PTPN23 HELZ R3HDM2 TAF4 TNRC6C EIF4G3 CREBBP ZYX YTHDF2 | 3.92e-10 | 312 | 82 | 13 | int:YTHDF2 |
| Interaction | CNOT3 interactions | YTHDF1 PRRC2C ANKRD17 HELZ R3HDM2 TNRC6C TRIM24 CREBBP EP300 YTHDF2 KDM1A | 7.62e-10 | 207 | 82 | 11 | int:CNOT3 |
| Interaction | BMI1 interactions | YTHDF1 PHC3 WBP11 SPATS2L PRRC2C SEC23IP LARP1 KMT2A HELZ PPHLN1 EIF4G3 SEC31B SPEN CREBBP EP300 YTHDF2 KDM1A | 1.02e-09 | 659 | 82 | 17 | int:BMI1 |
| Interaction | HNF4A interactions | NCOR2 ARID1B BICRA ARID2 ASXL2 TAF4 RREB1 TRIM24 SPEN CREBBP EP300 KDM1A | 1.16e-09 | 275 | 82 | 12 | int:HNF4A |
| Interaction | WWTR1 interactions | ARID1B PNN PRRC2C KLF5 ARID2 SEC23IP SEC16A LARP1 KMT2A PTPN23 NDN CREBBP ZYX EP300 | 1.51e-09 | 422 | 82 | 14 | int:WWTR1 |
| Interaction | NUP43 interactions | NCOR2 PHC3 ARID1B MRTFB PNN PRRC2C ARID2 LARP1 KMT2A PPHLN1 ASXL2 RERE TAF4 EIF4G3 SPEN PHF21A | 3.78e-09 | 625 | 82 | 16 | int:NUP43 |
| Interaction | EYA4 interactions | NCOR2 SPATS2L RBM33 BICRA AAK1 HELZ R3HDM2 TNRC6C KHDC4 CREBBP EP300 | 4.12e-09 | 243 | 82 | 11 | int:EYA4 |
| Interaction | KLF5 interactions | NCOR2 ARID1B KLF5 ARID2 SEC16A LARP1 TRIM24 CREBBP RBM20 EP300 | 6.67e-09 | 195 | 82 | 10 | int:KLF5 |
| Interaction | DAZL interactions | 7.55e-09 | 145 | 82 | 9 | int:DAZL | |
| Interaction | NAA40 interactions | PHC3 MRTFB PNN PRRC2C ARID2 SEC23IP SEC16A AAK1 LARP1 KMT2A ANKRD17 PTPN23 HELZ EIF4G3 WNK1 ZYX YTHDF2 PHF21A SCAF4 | 9.83e-09 | 978 | 82 | 19 | int:NAA40 |
| Interaction | AR interactions | DHX15 NCOR2 ARID1B SPATS2L PNN RBM33 KLF5 ARID2 SEC16A LARP1 KMT2A RERE RREB1 TRIM24 CREBBP EP300 KDM1A PHF21A RAI1 | 1.24e-08 | 992 | 82 | 19 | int:AR |
| Interaction | CPEB4 interactions | YTHDF1 PRRC2C CLPTM1 ANKRD17 HELZ R3HDM2 TNRC6C RNF43 YTHDF2 | 1.43e-08 | 156 | 82 | 9 | int:CPEB4 |
| Interaction | PML interactions | DHX15 IL12RB1 NCOR2 WBP11 SPATS2L HIPK1 SEC16A AAK1 LARP1 KMT2A RNF216 TAF4 TRIM24 CREBBP ZYX EP300 YTHDF2 PHF21A | 2.88e-08 | 933 | 82 | 18 | int:PML |
| Interaction | KLF3 interactions | NCOR2 ARID1B ARID2 KMT2A TAF4 RREB1 TRIM24 EP300 KDM1A PHF21A | 2.96e-08 | 228 | 82 | 10 | int:KLF3 |
| Interaction | CNOT9 interactions | YTHDF1 PRRC2C SEC23IP SEC16A ANKRD17 HELZ R3HDM2 TNRC6C RBM20 YTHDF2 | 3.35e-08 | 231 | 82 | 10 | int:CNOT9 |
| Interaction | QPRT interactions | 5.01e-08 | 84 | 82 | 7 | int:QPRT | |
| Interaction | ASF1A interactions | 6.79e-08 | 249 | 82 | 10 | int:ASF1A | |
| Interaction | CTBP1 interactions | NCOR2 PHC3 PNN SEC23IP SEC16A KMT2A HELZ RREB1 SPEN CREBBP EP300 KDM1A | 8.83e-08 | 406 | 82 | 12 | int:CTBP1 |
| Interaction | SUPT5H interactions | NCOR2 WBP11 ARID1B PNN RBM33 BICRA KMT2A NDN SPEN EP300 KDM1A SCAF4 | 9.32e-08 | 408 | 82 | 12 | int:SUPT5H |
| Interaction | FOXI1 interactions | 9.43e-08 | 92 | 82 | 7 | int:FOXI1 | |
| Interaction | PRRC2B interactions | YTHDF1 KLF5 SEC16A ANKRD17 HELZ R3HDM2 RERE RNF43 RBM20 YTHDF2 | 1.21e-07 | 265 | 82 | 10 | int:PRRC2B |
| Interaction | CPEB1 interactions | 1.42e-07 | 146 | 82 | 8 | int:CPEB1 | |
| Interaction | SEC16A interactions | NCOR2 PRRC2C KLF5 SEC16A PTPN23 HELZ R3HDM2 TNRC6C RNF43 ZYX KDM1A PHF21A | 1.49e-07 | 426 | 82 | 12 | int:SEC16A |
| Interaction | CLOCK interactions | 1.92e-07 | 102 | 82 | 7 | int:CLOCK | |
| Interaction | BAG2 interactions | PHC3 MRTFB RBM33 PRRC2C AAK1 SIK2 PTPN23 RREB1 EIF4G3 WNK1 SPEN CREBBP RNF43 EP300 | 1.95e-07 | 622 | 82 | 14 | int:BAG2 |
| Interaction | PUM1 interactions | YTHDF1 PRRC2C SEC16A ANKRD17 HELZ R3HDM2 TNRC6C TRIM24 EP300 YTHDF2 | 2.54e-07 | 287 | 82 | 10 | int:PUM1 |
| Interaction | SNRNP40 interactions | NCOR2 PHC3 WBP11 ARID1B PNN ARID2 KMT2A TAF4 TRIM24 SPEN KHDC4 RBM20 PHF21A SCAF4 | 2.61e-07 | 637 | 82 | 14 | int:SNRNP40 |
| Interaction | CELF1 interactions | YTHDF1 WBP11 RBM33 PRRC2C HELZ R3HDM2 TNRC6C RBM20 YTHDF2 SCAF4 | 2.63e-07 | 288 | 82 | 10 | int:CELF1 |
| Interaction | PAX6 interactions | HOXA4 NCOR2 ARID1B BICRA ARID2 ASXL2 RREB1 TRIM24 CREBBP EP300 PHF21A | 2.70e-07 | 366 | 82 | 11 | int:PAX6 |
| Interaction | KLF15 interactions | NCOR2 PRRC2C ARID2 SEC16A LARP1 TAF4 TRIM24 CREBBP EP300 YTHDF2 | 2.80e-07 | 290 | 82 | 10 | int:KLF15 |
| Interaction | MEX3B interactions | YTHDF1 VPS37C PRRC2C SEC16A ANKRD17 HELZ R3HDM2 TNRC6C YTHDF2 | 2.96e-07 | 222 | 82 | 9 | int:MEX3B |
| Interaction | ERG interactions | 3.08e-07 | 223 | 82 | 9 | int:ERG | |
| Interaction | HDAC2 interactions | DHX15 NCOR2 PRRC2C KLF5 KMT2A ANKRD17 RERE RREB1 WNK1 SPEN CREBBP ZYX EP300 KDM1A PHF21A RAI1 | 3.38e-07 | 865 | 82 | 16 | int:HDAC2 |
| Interaction | BMAL1 interactions | 3.44e-07 | 111 | 82 | 7 | int:BMAL1 | |
| Interaction | ANKRD17 interactions | 3.45e-07 | 226 | 82 | 9 | int:ANKRD17 | |
| Interaction | NFIX interactions | 3.58e-07 | 227 | 82 | 9 | int:NFIX | |
| Interaction | ETV4 interactions | 3.68e-07 | 69 | 82 | 6 | int:ETV4 | |
| Interaction | DCP1A interactions | 3.80e-07 | 166 | 82 | 8 | int:DCP1A | |
| Interaction | GARRE1 interactions | 3.98e-07 | 167 | 82 | 8 | int:GARRE1 | |
| Interaction | CNOT1 interactions | YTHDF1 ANKRD17 HELZ R3HDM2 TNRC6C TRIM24 RNF43 ZYX YTHDF2 KDM1A | 4.45e-07 | 305 | 82 | 10 | int:CNOT1 |
| Interaction | TBXT interactions | 4.64e-07 | 116 | 82 | 7 | int:TBXT | |
| Interaction | ATXN2 interactions | DHX15 YTHDF1 SEC16A LARP1 ANKRD17 PTPN23 HELZ R3HDM2 RNF43 YTHDF2 | 5.47e-07 | 312 | 82 | 10 | int:ATXN2 |
| Interaction | YTHDF3 interactions | 7.02e-07 | 246 | 82 | 9 | int:YTHDF3 | |
| Interaction | ZFP36 interactions | 7.33e-07 | 181 | 82 | 8 | int:ZFP36 | |
| Interaction | SOX2 interactions | DHX15 YTHDF1 NCOR2 PHC3 ARID1B SPATS2L KLF5 ARID2 SEC16A LARP1 KMT2A ANKRD17 HELZ EIF4G3 TRIM24 SPEN EP300 YTHDF2 ALX4 KDM1A | 7.42e-07 | 1422 | 82 | 20 | int:SOX2 |
| Interaction | H2BC21 interactions | DHX15 ARID1B MRTFB PNN ARID2 KMT2A PPHLN1 RREB1 TRIM24 CREBBP EP300 KDM1A RAI1 SCAF4 | 7.55e-07 | 696 | 82 | 14 | int:H2BC21 |
| Interaction | PRMT1 interactions | DHX15 YTHDF1 CCDC88C PNN FNTA PRRC2C SEC16A LARP1 PPHLN1 NDN ASXL2 TAF4 ZYX EP300 YTHDF2 KDM1A | 8.72e-07 | 929 | 82 | 16 | int:PRMT1 |
| Interaction | ZYX interactions | 8.87e-07 | 329 | 82 | 10 | int:ZYX | |
| Interaction | RBPJ interactions | 9.16e-07 | 254 | 82 | 9 | int:RBPJ | |
| Interaction | CEBPB interactions | DHX15 YTHDF1 NCOR2 PHC3 WBP11 PNN PRRC2C KLF5 CLPTM1 SEC23IP LARP1 PPHLN1 ASXL2 TRIM24 CREBBP ZYX EP300 YTHDF2 KDM1A SCAF4 | 9.33e-07 | 1443 | 82 | 20 | int:CEBPB |
| Interaction | R3HDM2 interactions | 9.54e-07 | 129 | 82 | 7 | int:R3HDM2 | |
| Interaction | SMAP2 interactions | 1.02e-06 | 189 | 82 | 8 | int:SMAP2 | |
| Interaction | FASN interactions | DHX15 BICRA ARID2 TMEM165 SEC16A KMT2A HELZ PPHLN1 NDN ASXL2 RERE TAF4 WNK1 EP300 YTHDF2 KDM1A CAPN15 | 1.03e-06 | 1062 | 82 | 17 | int:FASN |
| Interaction | IMPDH2 interactions | DHX15 MRTFB SEC23IP SEC16A AAK1 LARP1 PTPN23 NDN ASXL2 TAF4 WNK1 | 1.05e-06 | 420 | 82 | 11 | int:IMPDH2 |
| Interaction | HNF1B interactions | 1.06e-06 | 190 | 82 | 8 | int:HNF1B | |
| Interaction | FAM120C interactions | 1.10e-06 | 191 | 82 | 8 | int:FAM120C | |
| Interaction | GSC interactions | 1.46e-06 | 87 | 82 | 6 | int:GSC | |
| Interaction | GATA2 interactions | 1.50e-06 | 199 | 82 | 8 | int:GATA2 | |
| Interaction | TNRC6C interactions | 1.50e-06 | 138 | 82 | 7 | int:TNRC6C | |
| Interaction | YAP1 interactions | DHX15 ARID1B MRTFB PNN PRRC2C KLF5 ARID2 SEC16A LARP1 KMT2A TAF4 SPEN CREBBP ZYX EP300 KDM1A SCAF4 | 1.57e-06 | 1095 | 82 | 17 | int:YAP1 |
| Interaction | N4BP2 interactions | 1.67e-06 | 89 | 82 | 6 | int:N4BP2 | |
| Interaction | PABPC4 interactions | DHX15 YTHDF1 PNN LARP1 HELZ NDN TNRC6C EIF4G3 RNF43 EP300 YTHDF2 | 1.72e-06 | 442 | 82 | 11 | int:PABPC4 |
| Interaction | TERF2IP interactions | NCOR2 PHC3 WBP11 ARPP21 KMT2A TAF4 RREB1 TRIM24 SPEN CREBBP KDM1A RAI1 | 2.29e-06 | 552 | 82 | 12 | int:TERF2IP |
| Interaction | ELF5 interactions | 2.29e-06 | 147 | 82 | 7 | int:ELF5 | |
| Interaction | TDRD3 interactions | 2.40e-06 | 212 | 82 | 8 | int:TDRD3 | |
| Interaction | PRRC2C interactions | 2.73e-06 | 290 | 82 | 9 | int:PRRC2C | |
| Interaction | SOX9 interactions | 2.77e-06 | 97 | 82 | 6 | int:SOX9 | |
| Interaction | AGO3 interactions | 2.99e-06 | 153 | 82 | 7 | int:AGO3 | |
| Interaction | DCAF4 interactions | YTHDF1 NCOR2 SPATS2L SEC16A HELZ R3HDM2 TNRC6C SPEN EP300 YTHDF2 | 3.08e-06 | 378 | 82 | 10 | int:DCAF4 |
| Interaction | FXR1 interactions | DHX15 YTHDF1 WASH6P NCOR2 PLK2 PRRC2C SEC16A AAK1 ANKRD17 HELZ PPHLN1 EP300 YTHDF2 | 3.38e-06 | 679 | 82 | 13 | int:FXR1 |
| Interaction | UBAP2L interactions | 3.41e-06 | 298 | 82 | 9 | int:UBAP2L | |
| Interaction | NCOA3 interactions | 3.61e-06 | 224 | 82 | 8 | int:NCOA3 | |
| Interaction | MKRN2 interactions | PRRC2C LARP1 HELZ R3HDM2 NDN TNRC6C RNF43 EP300 YTHDF2 KDM1A | 3.63e-06 | 385 | 82 | 10 | int:MKRN2 |
| Interaction | PRRC2A interactions | YTHDF1 PRRC2C KLF5 SEC16A ANKRD17 HELZ R3HDM2 RERE TNRC6C YTHDF2 | 3.97e-06 | 389 | 82 | 10 | int:PRRC2A |
| Interaction | RNF113A interactions | DHX15 NCOR2 PNN PRRC2C SEC16A LARP1 ANKRD17 HELZ RERE TAF4 ZYX YTHDF2 KDM1A | 4.15e-06 | 692 | 82 | 13 | int:RNF113A |
| Interaction | MRTFA interactions | 4.52e-06 | 60 | 82 | 5 | int:MRTFA | |
| Interaction | TRIM24 interactions | DHX15 KLF5 ANKRD17 HELZ TNRC6C TRIM24 CREBBP RNF43 EP300 KDM1A | 4.86e-06 | 398 | 82 | 10 | int:TRIM24 |
| Interaction | MAGEL2 interactions | 4.90e-06 | 61 | 82 | 5 | int:MAGEL2 | |
| Interaction | CREBBP interactions | NCOR2 ARID1B KLF5 HIPK1 KMT2A HELZ TRIM24 CREBBP EP300 YTHDF2 SERTAD3 NPAS2 | 5.29e-06 | 599 | 82 | 12 | int:CREBBP |
| Interaction | CEP85 interactions | 5.77e-06 | 169 | 82 | 7 | int:CEP85 | |
| Interaction | LARP4B interactions | 6.01e-06 | 240 | 82 | 8 | int:LARP4B | |
| GeneFamily | AT-rich interaction domain containing | 7.69e-04 | 15 | 50 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.93e-04 | 17 | 50 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-03 | 18 | 50 | 2 | 91 | |
| GeneFamily | PHD finger proteins | 1.97e-03 | 90 | 50 | 3 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.16e-03 | 25 | 50 | 2 | 775 | |
| GeneFamily | RNA binding motif containing | 2.82e-03 | 213 | 50 | 4 | 725 | |
| GeneFamily | Complement system|Sushi domain containing | 4.45e-03 | 36 | 50 | 2 | 492 | |
| GeneFamily | MAGE family | 5.47e-03 | 40 | 50 | 2 | 1136 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.44e-03 | 53 | 50 | 2 | 532 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | CCDC88C PHC3 PNN FNTA RBM33 HIPK1 ARID2 RETREG1 AAK1 KMT2A HELZ RNF216 PPHLN1 ASXL2 TNRC6C WNK1 SPEN CREBBP ZYX EP300 | 2.34e-08 | 1492 | 82 | 20 | M40023 |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN | 6.31e-07 | 157 | 82 | 7 | M7733 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DHX15 PRRC2C ANKRD17 HELZ R3HDM2 TAF4 EIF4G3 SPEN CREBBP PHF21A | 1.95e-06 | 466 | 82 | 10 | M13522 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DHX15 NCOR2 PRRC2C CDK19 ANKRD17 HELZ R3HDM2 TAF4 EIF4G3 TRIM24 SPEN CREBBP PHF21A | 2.44e-06 | 856 | 82 | 13 | M4500 |
| Coexpression | GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN | 2.97e-06 | 198 | 82 | 7 | M3248 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 3.07e-06 | 199 | 82 | 7 | M9443 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN | 3.18e-06 | 200 | 82 | 7 | M9784 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 7.14e-06 | 85 | 82 | 5 | M41085 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 2.86e-05 | 634 | 82 | 10 | M40866 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP | 4.35e-05 | 22 | 82 | 3 | M40867 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN | 7.79e-05 | 72 | 82 | 4 | M40882 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 9.25e-05 | 338 | 82 | 7 | M17094 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | PRRC2C HIPK1 ARID2 AAK1 KMT2A HELZ ASXL2 TNRC6C WNK1 CREBBP ZYX | 1.24e-04 | 911 | 82 | 11 | M40038 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.69e-09 | 193 | 82 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.56e-09 | 200 | 82 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.70e-08 | 192 | 82 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.35e-06 | 103 | 82 | 5 | 1b2edf25d6b845e7c07470b2a034654d63917c01 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 190 | 82 | 6 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.49e-06 | 192 | 82 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.89e-06 | 200 | 82 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-05 | 169 | 82 | 5 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 176 | 82 | 5 | dca70f309af24421f8dc708cbd88512814b8e79e | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-05 | 186 | 82 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-05 | 186 | 82 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.41e-05 | 186 | 82 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.54e-05 | 188 | 82 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 82 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 2.88e-05 | 193 | 82 | 5 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 3.10e-05 | 196 | 82 | 5 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.18e-05 | 197 | 82 | 5 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.33e-05 | 199 | 82 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.41e-05 | 200 | 82 | 5 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 3.41e-05 | 200 | 82 | 5 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.92e-06 | 182 | 81 | 7 | 3887_DN | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.44e-06 | 2 | 81 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.44e-06 | 2 | 81 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 7.44e-06 | 2 | 81 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.44e-06 | 2 | 81 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 7.44e-06 | 2 | 81 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.44e-06 | 2 | 81 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.44e-06 | 2 | 81 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 7.44e-06 | 2 | 81 | 2 | C0035934 | |
| Disease | colorectal cancer (is_implicated_in) | 2.13e-05 | 121 | 81 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Chromosome 11p11.2 Deletion Syndrome | 2.23e-05 | 3 | 81 | 2 | C1832588 | |
| Disease | serum gamma-glutamyl transferase measurement | IL12RB1 SEC16B NCOR2 ARPP21 BICRA KLF5 KMT2A TAF4 RREB1 ZYX KDM1A | 3.98e-05 | 914 | 81 | 11 | EFO_0004532 |
| Disease | Bladder Neoplasm | 4.29e-05 | 140 | 81 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 4.44e-05 | 141 | 81 | 5 | C0005684 | |
| Disease | Neuropathy, Hereditary Sensory And Autonomic, Type IIA | 4.45e-05 | 4 | 81 | 2 | C2752089 | |
| Disease | Hereditary sensory and autonomic neuropathy type 2 | 4.45e-05 | 4 | 81 | 2 | cv:C5574675 | |
| Disease | Neuropathy, hereditary sensory and autonomic, type 2A | 4.45e-05 | 4 | 81 | 2 | cv:C2752089 | |
| Disease | NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA | 4.45e-05 | 4 | 81 | 2 | 201300 | |
| Disease | Prader-Willi syndrome (implicated_via_orthology) | 4.45e-05 | 4 | 81 | 2 | DOID:11983 (implicated_via_orthology) | |
| Disease | atrial fibrillation | 7.35e-05 | 371 | 81 | 7 | EFO_0000275 | |
| Disease | C-reactive protein measurement | IL12RB1 SEC16B ARPP21 CLPTM1 SEC16A R3HDM2 RERE TAF4 RREB1 EIF4G3 PHF21A SCAF4 | 1.08e-04 | 1206 | 81 | 12 | EFO_0004458 |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 1.11e-04 | 6 | 81 | 2 | DOID:4479 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 1.17e-04 | 173 | 81 | 5 | C0023467 | |
| Disease | Pancreatic Neoplasm | 1.69e-04 | 100 | 81 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.83e-04 | 102 | 81 | 4 | C0346647 | |
| Disease | Carcinoma, Transitional Cell | 1.97e-04 | 41 | 81 | 3 | C0007138 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.04e-04 | 195 | 81 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | central serous retinopathy | 2.06e-04 | 8 | 81 | 2 | EFO_0009784 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.63e-04 | 206 | 81 | 5 | C0152013 | |
| Disease | Prostatic Cancer, Castration-Resistant | 2.65e-04 | 9 | 81 | 2 | C3658266 | |
| Disease | Prostatic Neoplasms, Castration-Resistant | 2.65e-04 | 9 | 81 | 2 | C3658267 | |
| Disease | C3 glomerulopathy | 2.65e-04 | 9 | 81 | 2 | C4087273 | |
| Disease | synaptotagmin-11 measurement | 2.65e-04 | 9 | 81 | 2 | EFO_0802108 | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 3.30e-04 | 10 | 81 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | hemopexin measurement | 4.03e-04 | 11 | 81 | 2 | EFO_0008149 | |
| Disease | hematocrit | NCOR2 ARID1B ARID2 AAK1 ANKRD17 R3HDM2 ASXL2 RREB1 RNF43 RAI1 | 4.43e-04 | 1011 | 81 | 10 | EFO_0004348 |
| Disease | Small cell carcinoma of lung | 4.47e-04 | 54 | 81 | 3 | C0149925 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.72e-04 | 55 | 81 | 3 | C0079744 | |
| Disease | Royer Syndrome | 4.83e-04 | 12 | 81 | 2 | C0265222 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 4.83e-04 | 12 | 81 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | cognitive function measurement | DHX15 SEC16B PLK2 ARID1B ARPP21 SPATS2L CCDC185 PRRC2C RNF216 ASXL2 WNK2 NPAS2 | 5.24e-04 | 1434 | 81 | 12 | EFO_0008354 |
| Disease | HbA1c measurement | 5.33e-04 | 675 | 81 | 8 | EFO_0004541 | |
| Disease | essential tremor | 5.46e-04 | 136 | 81 | 4 | EFO_0003108 | |
| Disease | Coffin-Siris syndrome | 5.69e-04 | 13 | 81 | 2 | C0265338 | |
| Disease | Benign tumor of pancreas | 5.69e-04 | 13 | 81 | 2 | C0347284 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 5.69e-04 | 13 | 81 | 2 | C0270914 | |
| Disease | Prader-Willi Syndrome | 5.69e-04 | 13 | 81 | 2 | C0032897 | |
| Disease | JT interval | 6.14e-04 | 248 | 81 | 5 | EFO_0007885 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 6.39e-04 | 61 | 81 | 3 | C1961102 | |
| Disease | T-Cell Lymphoma | 8.71e-04 | 16 | 81 | 2 | C0079772 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 9.34e-04 | 157 | 81 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | comparative body size at age 10, self-reported | 1.06e-03 | 420 | 81 | 6 | EFO_0009819 | |
| Disease | angiopoietin-related protein 1 measurement | 1.11e-03 | 18 | 81 | 2 | EFO_0801382 | |
| Disease | risk-taking behaviour | 1.19e-03 | 764 | 81 | 8 | EFO_0008579 | |
| Disease | complement factor H-related protein 3 measurement | 1.23e-03 | 169 | 81 | 4 | EFO_0600056 | |
| Disease | Pancreatic carcinoma | 1.23e-03 | 19 | 81 | 2 | C0235974 | |
| Disease | coagulation factor measurement | 1.37e-03 | 20 | 81 | 2 | EFO_0004634 | |
| Disease | balding measurement | 1.49e-03 | 792 | 81 | 8 | EFO_0007825 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.51e-03 | 21 | 81 | 2 | DOID:0014667 (implicated_via_orthology) | |
| Disease | coffee consumption measurement | 1.61e-03 | 182 | 81 | 4 | EFO_0006781 | |
| Disease | breast carcinoma | 1.90e-03 | 1019 | 81 | 9 | EFO_0000305 | |
| Disease | age-related macular degeneration | 1.91e-03 | 89 | 81 | 3 | EFO_0001365 | |
| Disease | gout | 2.11e-03 | 196 | 81 | 4 | EFO_0004274 | |
| Disease | reaction time measurement | 2.22e-03 | 658 | 81 | 7 | EFO_0008393 | |
| Disease | S-warfarin measurement | 2.44e-03 | 97 | 81 | 3 | EFO_0803323 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.52e-03 | 206 | 81 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | Liver carcinoma | 2.73e-03 | 507 | 81 | 6 | C2239176 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPQPQPPAQPHLYLQ | 111 | Q9H161 | |
| WQPQTQLPPQRPQPC | 121 | Q8N715 | |
| PAPQVQQPGLVTPVA | 306 | Q09472 | |
| QPTAPPQQAAAPPQA | 381 | Q9BWU1 | |
| QPQPAAAPQPAPAQE | 576 | Q2M2I8 | |
| KLILPAPQIPPPNNA | 1076 | Q68CP9 | |
| NQPALPAPGAQPPVI | 681 | Q92793 | |
| QPPVIPQAQPVRPPN | 691 | Q92793 | |
| QQPQPPHLPPQAQYL | 686 | Q8NFD5 | |
| AQIQLCPPPPQIPNS | 806 | P08603 | |
| SQEPRPPLQQSQVPP | 2116 | O75179 | |
| TLPPQQQQRIFEPPP | 391 | O43143 | |
| QVLQPPPSPQGFVQQ | 616 | Q9UBL0 | |
| AQLQQTPPVPPTPAV | 771 | Q76L83 | |
| ALPPTPQQQPPLNNH | 416 | Q9Y2K5 | |
| LHVQQPPPPQQPLAY | 171 | Q7Z5J4 | |
| PPPPQAGLPQIIQNA | 51 | Q5T481 | |
| PPQQQPIRSLFQPQP | 326 | Q96EV2 | |
| AFGPQPPQQPLPLQH | 966 | Q9H3S7 | |
| LAVPPALQPQPEQQP | 51 | Q68EN5 | |
| PSPLQPAQARQQPPQ | 746 | Q99743 | |
| VPPQLQPPVPEAAQP | 251 | O75808 | |
| PPQNLQPESDAPQQP | 1001 | Q9Y618 | |
| PNQEVPPGPPRFQQV | 731 | Q6PKG0 | |
| QSQVIRAPPQVPQGP | 341 | Q9UJ55 | |
| PIVPQAPAAQPLQIQ | 681 | Q86Z02 | |
| EAPPSVAPRQAQPPQ | 1761 | Q9P219 | |
| SEPQPEPVAQPQPQS | 466 | Q9H307 | |
| SQGQPPPAVVAQPQA | 691 | Q9ULH7 | |
| QATPPQPIKVPQFIP | 206 | Q96BD5 | |
| PKPVAQNNIPIAPAP | 236 | Q96BD5 | |
| QSPPAEAVIPEQQPP | 1441 | P42694 | |
| NLQVQPPAPVDPPVV | 571 | Q8NDX5 | |
| FPPPVPNPFVQQTQI | 36 | Q7L5N7 | |
| KQQPPAVQFVPPLPE | 631 | O60341 | |
| AECPPPRQPQPAQNV | 26 | Q6EEV4 | |
| PQQPLIAQIPPPQAF | 216 | P58505 | |
| GQQQVLPPPPLVPVV | 191 | Q8NI99 | |
| EQFCPPPPQIPNAQN | 386 | Q9BXR6 | |
| VPPENPPQPQVRFSV | 231 | P42701 | |
| QQPVQPPYGVPSIVP | 371 | Q7Z7F0 | |
| KQVSQPALVIPPQPP | 1296 | Q03164 | |
| PQQAQALGIPLIPPQ | 1521 | A6NE01 | |
| VIQNQLGVPPPASNP | 836 | Q9NZM4 | |
| QPVIPPTPPVQQPFQ | 381 | O95104 | |
| PAPPTQHLPLQQPQL | 46 | Q00056 | |
| SAPIIVPTQQQPPPA | 121 | O43432 | |
| ETAQSAPQPPQAPQP | 371 | Q8NEY8 | |
| VLAPRLPQPPQNPTN | 431 | O00268 | |
| QARTMQQPPQPPVQP | 1086 | Q9HCJ0 | |
| PEAGPLQPQPPQIQN | 91 | Q9NUQ6 | |
| SPPPPQASPAERQQQ | 26 | Q9H6L5 | |
| VDPPPIPVNCAIPNQ | 11 | Q8WWF3 | |
| DVLPPSQPQAPPQQA | 1476 | P57071 | |
| DPVPQNDGPNPVVQI | 76 | P49354 | |
| IQPQSVPPPIQPEAE | 1071 | Q9Y520 | |
| APNPAPPAPAQTQAQ | 1921 | Q9Y520 | |
| QPQPEPPSPDQQVTR | 586 | Q68DV7 | |
| QPSQQLPLPRQETPP | 746 | Q9H0K1 | |
| VEALPRPVPQNLPQP | 781 | Q9NWF9 | |
| ALQSQQPPREQPLPP | 906 | Q9P2R6 | |
| GQPLPPLQVPEQVAQ | 356 | Q9NQW1 | |
| IAPPQLQQCQTPGPP | 196 | Q9Y6Y8 | |
| VKQPSQPPPQEIFVP | 21 | Q9UBC9 | |
| PPQNPVTPLGLQNEV | 111 | Q9UJW9 | |
| PQNPPAQPAPNAWQV | 41 | O96005 | |
| MIPPEQPQQQLQPPS | 1 | Q5T1Q4 | |
| PPNQNIPRQAIKPNP | 541 | O15164 | |
| LQPPQPVQSTQPAQP | 3351 | Q96T58 | |
| VQPPSQPVPENLVPE | 926 | O15027 | |
| PEPPAQPLQGPVQLA | 1001 | Q92766 | |
| PLPRTEPQNNPVVPA | 41 | A7MD48 | |
| PPAPAQQLQPQPVAV | 46 | Q9HC07 | |
| QQLQPQPVAVQGPEP | 51 | Q9HC07 | |
| PPPPPSQEQQDQLTQ | 311 | Q8IYU4 | |
| CLLQPSPQQPFPLQP | 766 | Q96JE7 | |
| PVPPPAQNQNQVRSP | 331 | Q15942 | |
| PQPPEESQPPQSQAQ | 36 | Q9NYY3 | |
| PPLVQPVANVPAVQQ | 1601 | Q9H4A3 | |
| QPTPLPQVLAPQPVV | 736 | Q9Y3S1 | |
| PQVLAPQPVVPLQPV | 741 | Q9Y3S1 | |
| QAPPQSVPPSQIQAP | 391 | Q9Y2W2 | |
| PVPQGTPPVVEEQPQ | 181 | A5D8V6 | |
| SIPPVPPPQQPQAEE | 426 | Q9NQA3 | |
| PPPPQPAQLSVQQQA | 331 | Q9Y5A9 | |
| VAQPLPAQPPALAQP | 301 | Q9BYJ9 | |
| PQPPAPQDEPVFAQL | 16 | Q13887 | |
| AQPGPAPPAPAQLVQ | 86 | Q99608 |